Film phase:Completed
SYNOPSIS
In the shocking and hilarious documentary Orgasm Inc., filmmaker Liz Canner edits erotic videos for a pharmaceutical company. Her employer is racing to develop the first FDA-approved Viagra for women. She soon begins to suspect that they, along with other drug companies, might be trying to take advantage of women. Orgasm Inc. presents an extraordinary behind-the-scenes look at the cash-fueled pharmaceutical industry and the way it is reshaping our idea of health, illness, and…orgasm.
ABOUT THE DIRECTOR
Award-winning filmmaker Liz Canner has produced many documentaries and transmedia projects on human rights issues. Her film Deadly Embrace was one of the first documentaries to explore the impact of globalization. She has received over 55 awards and honors including fellowships from the Rockefeller Foundation and the Radcliffe Institute for Advanced Study, and a National Endowment for the Arts grant. Liz’s award-winning documentaries have been theatrically released, shown extensively on the festival circuit, on Netflix and broadcast on PBS, cable stations and internationally in many countries.
NOW PLAYING
Orgasm Inc. reached a large audience through traditional distribution platforms and a grassroots educational campaign. It was broadcast on television stations in 11 countries, theatrically released in 41 cities in the U.S., Canada and Korea, screened at over 65 film festivals, streamed on Netflix (“Most Popular” Critically Acclaimed Documentary section in Winter 2012), presented on VOD, iTunes, Amazon and in stores. The documentary was also used in an educational campaign to challenge misinformation promoted by pharmaceutical industry marketers. It educated journalists, students and medical experts about the real story behind FSD and the marketing techniques of the pharmaceutical industry such as “condition branding” and deceitful statistics. The result was major improvement in press coverage of the issue, thousands of students reached and presentations to hundreds of medical experts at conferences and medical schools. The 2050 Group estimated that combined media coverage and distribution of Orgasm Inc. reached 100 million people.